Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
321.13Price to Sales
VS
Market
Sector
Industry
History
$ 0.23Close
$ 0.19 - $ 0.44 52-Week Range
Ticker Information
Ticker
NWBOCompany Name
NORTHWEST BIOTHERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
OTCNORTHWEST BIOTHERAPEUTICS INC - Price to Sales Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
NWBO - P/S Historical data
| Date | Market Capitalization | Price to Sales | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 351.32M | 321.13 | $ 1.09M |
| 3/31/2025 | $ 416.93M | 283.05 | $ 1.47M |
| 12/31/2024 | $ 319.87M | 231.46 | $ 1.38M |
| 9/30/2024 | $ 408.7M | 256.07 | $ 1.6M |
| 6/30/2024 | $ 374.47M | 227.64 | $ 1.65M |
| 3/31/2024 | $ 589.59M | 441.31 | $ 1.34M |
| 12/31/2023 | $ 667.57M | 345.53 | $ 1.93M |
| 9/30/2023 | $ 1.03B | 492.77 | $ 2.08M |
| 6/30/2023 | $ 560.54M | 297.52 | $ 1.88M |
| 3/31/2023 | $ 633.59M | 293.33 | $ 2.16M |
Key Performance Insights, Last 5 Years
- NORTHWEST BIOTHERAPEUTICS INC's latest trailing twelve months (TTM) P/S stands at 659.15.
- Over the past 5 years, NORTHWEST BIOTHERAPEUTICS INC's average P/S has been 555.37.
- The median P/S for NORTHWEST BIOTHERAPEUTICS INC during this period was 467.04
- NORTHWEST BIOTHERAPEUTICS INC reached its highest P/S over the past 5 years at 1.73K.
- The lowest P/S recorded by NORTHWEST BIOTHERAPEUTICS INC in the same timeframe 227.64
NORTHWEST BIOTHERAPEUTICS INC's P/S vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/S Benchmarks
Similar metrics to Revenues:
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Price to Book - [Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
Definition of Price to Sales
[Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].Market Cap / Revenues
(=) P/S P/S for NORTHWEST BIOTHERAPEUTICS INC is calculated as follows: Market Cap [ $ 1.11B ] / Revenues [ $ 1.69M ]
(=) P/S [ 659.15 ] NWBO - Price to Sales, Last 5 years
227.64
Minimum
Jun 30, 2024
1.73K
Maximum
Mar 31, 2021
555.37
Average
467.04
Median
P/S Benchmark AnalysisMarket
The chart above depicts the distribution of P/S for companies in the Total Stock Market. The average P/S of the companies is 2.62 with a standard deviation of 2.38.
The following table provides additional summary stats:
P/S in the Market:
| filtered constituents | 3.42K |
|---|---|
| min | 0 |
| max | 11.15 |
| average | 2.62 |
| median | 1.97 |
| std | 2.38 |